Discussion
Daidzein (4,7-dihydroxy-isoflavone) is one of the effective principals of soy isoflavone. This hasbeen pharmacologically shown with the effects of being antioxidant [1] , potentialphytoestrogen [2, 3] or inhibiting cancer cells growth [4, 5] , inhibiting cardiovasculardisease [6, 7] , and playing the role of female hormone [8] . Because the solubility of daidzein is poor, its biologicalutilization rate is low and the dose is high. Thus, it is necessary to synthesize awatersolublederivative of daidzein in order to study its possible biologicaleffects. Wealready hadsynthesized the derivatives of daidzein, and studied their structures and biologicalactivities [9, 10] . Ino rder to prepare 3 ¢ -amino-4¢ ,7-dihydroxyisoflavone,i ts intermediate 3 ¢ -nitro-4¢ ,7-dihydroxyisoflavone was synthesized and the crystalstructure wasdetermined. Inthe crystalstructure of 3 ¢ -nitro-4¢ ,7-dihydroxyisoflavone, the atoms of benzopyranone moietyare in anearly coplanarc onfiguration with ameand eviation to their least-squares plane being 0.019 Å(A:C9 ® C15, C:C7 ® C11/O1; figure, top). To avoid steric conflicts, the two rigid ring systems,phenyl rings B (C1 ® C6) and benzopyranone moieties are rotated by 129.8°with respect to each other. Paired O3-H3···O2 i (symmetry code: 
cross the layer. The p -p stacking interactions exist betweenthe dimers. A p 9 10 conjugation system is composed of ring B(C1 ® C6) and atoms O2, O3, N1. The aromatic p -p stacking is thatthe p 9 10 conjugation system at x , y , z stackswith p 9 10 conjugation system at1-x,-y ,1-z of an adjacent molecule with the distance of Cgand Cg vi being 3.521 Å atthe normalrange (3.5 Å-3.8 Å)ofaromatic p -p stacking interaction, where Cgand Cg vi are the centers of p 9 10 conjugation system atthe symmetry position (vi) of 1-x ,-y ,1-z ,respectively. A three-dimensionals upramoleculars tructure is generated by the hydrogen bonds and the aromatic stacking interactions (figure, bottom). (5) 
